X20 JSC (HNX:X20)
Vietnam · Delayed Price · Currency is VND 12,000
-100 (-0.83%)
At close: Aug 14, 2026
X20 JSC Revenue
X20 JSC had revenue of 226.81B VND in the quarter ending June 30, 2026, with 32.29% growth. This brings the company's revenue in the last twelve months to 1.20T, down -2.21% year-over-year. In the year 2025, X20 JSC had annual revenue of 1.12T, down -14.31%.
Revenue (ttm)
1.20T
Revenue Growth
-2.21%
P/S Ratio
0.17
Revenue / Employee
625.80M
Employees
1,922
Market Cap
207.00B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.12T | -186.22B | -14.31% |
| Dec 31, 2024 | 1.30T | 267.37B | 25.85% |
| Jan 1, 2024 | 1.03T | -109.48B | -9.57% |
| Dec 31, 2022 | 1.14T | 180.31B | 18.71% |
| Dec 31, 2021 | 963.56B | 188.63B | 24.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| The Vegetexco Port JSC | 12.95T |
| Petro Vietnam LPG JSC | 6.56T |
| Central PetroVietnam Fertilizer And Chemicals JSC | 3.72T |
| Vinacomin - Mong Duong Coal JSC | 2.44T |
| Kien Hung JSC | 726.45B |
| DIN Capital Investment Group JSC | 440.08B |
| Dong A Paint JSC | 293.42B |
| Mediplantex National Pharmaceutical JSC | 291.40B |